Valiant Organics Share Price
Sector: Chemical Manufacturing
462.40 +4.35 (0.95%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
448.30
Today’s High
470.05
52 Week Low
225.00
52 Week High
468.00
459.50 +0.10 (0.02%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
449.95
Today’s High
471.00
52 Week Low
227.05
52 Week High
468.60
Key Metrics
- Market Cap (In Cr) 1294.93
- Beta 0.95
- Div. Yield (%) 0
- P/B 1.77
- TTM P/E -
- Peg Ratio -
- Sector P/E 17.2
- D/E 0
- Open Price 465.1
- Prev Close 458.05
Valiant Organics Analysis
Price Analysis
-
1 Week16.04%
-
3 Months79.8%
-
6 Month36.97%
-
YTD49.96%
-
1 Year17.48%
Risk Meter
- 56% Low risk
- 56% Moderate risk
- 56% Balanced Risk
- 56% High risk
- 56% Extreme risk
Valiant Organics News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 09 Apr 2025These three beaten-down stocks are prime candidates for a turnaround
5 min read . 23 Oct 2024Buy or sell: Vaishali Parekh recommends three stocks to buy today — August 27
2 min read . 27 Aug 2024Valiant Organics Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 718.76
- Selling/ General/ Admin Expenses Total
- 44.99
- Depreciation/ Amortization
- 35.76
- Other Operating Expenses Total
- 162.95
- Total Operating Expense
- 700.85
- Operating Income
- 17.92
- Net Income Before Taxes
- 2.15
- Net Income
- -3.74
- Diluted Normalized EPS
- -1.24
- Period
- 2025
- Total Assets
- 1182.93
- Total Liabilities
- 457.67
- Total Equity
- 725.26
- Tangible Book Valueper Share Common Eq
- 254.42
- Period
- 2025
- Cashfrom Operating Activities
- 56.43
- Cashfrom Investing Activities
- -20.96
- Cashfrom Financing Activities
- -31.81
- Net Changein Cash
- 3.66
- Period
- 2024
- Total Revenue
- 723.06
- Selling/ General/ Admin Expenses Total
- 145.68
- Depreciation/ Amortization
- 34.92
- Other Operating Expenses Total
- 9.98
- Total Operating Expense
- 723.07
- Operating Income
- -0.01
- Net Income Before Taxes
- -8.14
- Net Income
- -7.83
- Diluted Normalized EPS
- -2.14
- Period
- 2024
- Total Assets
- 1247.96
- Total Liabilities
- 518.67
- Total Equity
- 729.29
- Tangible Book Valueper Share Common Eq
- 259.92
- Period
- 2024
- Cashfrom Operating Activities
- 83.84
- Cashfrom Investing Activities
- -64.99
- Cashfrom Financing Activities
- -4.06
- Net Changein Cash
- -4.27
- Period
- 2023
- Total Revenue
- 1051.8
- Selling/ General/ Admin Expenses Total
- 152.8
- Depreciation/ Amortization
- 29.19
- Other Operating Expenses Total
- 10.46
- Total Operating Expense
- 911.58
- Operating Income
- 140.22
- Net Income Before Taxes
- 137.18
- Net Income
- 88.12
- Diluted Normalized EPS
- 30.18
- Period
- 2023
- Total Assets
- 1239.23
- Total Liabilities
- 550.05
- Total Equity
- 689.18
- Tangible Book Valueper Share Common Eq
- 249.19
- Period
- 2023
- Cashfrom Operating Activities
- 237.93
- Cashfrom Investing Activities
- -142.74
- Cashfrom Financing Activities
- -112.48
- Net Changein Cash
- -17.3
- Period
- 2022
- Total Revenue
- 1153.27
- Selling/ General/ Admin Expenses Total
- 138.92
- Depreciation/ Amortization
- 29.62
- Other Operating Expenses Total
- 5.07
- Total Operating Expense
- 977.12
- Operating Income
- 176.15
- Net Income Before Taxes
- 176.17
- Net Income
- 113.28
- Diluted Normalized EPS
- 40.5
- Period
- 2022
- Total Assets
- 1184.75
- Total Liabilities
- 571.6
- Total Equity
- 613.15
- Tangible Book Valueper Share Common Eq
- 221.27
- Period
- 2022
- Cashfrom Operating Activities
- -32.47
- Cashfrom Investing Activities
- -122.23
- Cashfrom Financing Activities
- 166.91
- Net Changein Cash
- 12.21
- Period
- 2021
- Total Revenue
- 754.81
- Selling/ General/ Admin Expenses Total
- 107.72
- Depreciation/ Amortization
- 18.42
- Other Operating Expenses Total
- -1.85
- Total Operating Expense
- 568.48
- Operating Income
- 186.32
- Net Income Before Taxes
- 184.86
- Net Income
- 114.56
- Diluted Normalized EPS
- 41.68
- Period
- 2021
- Total Assets
- 875.85
- Total Liabilities
- 373.58
- Total Equity
- 502.27
- Tangible Book Valueper Share Common Eq
- 180.43
- Period
- 2021
- Cashfrom Operating Activities
- 115.1
- Cashfrom Investing Activities
- -158.59
- Cashfrom Financing Activities
- 48.67
- Net Changein Cash
- 5.18
- Period
- 2020
- Total Revenue
- 674.93
- Selling/ General/ Admin Expenses Total
- 80.63
- Depreciation/ Amortization
- 12.01
- Other Operating Expenses Total
- -1.81
- Total Operating Expense
- 508.54
- Operating Income
- 166.39
- Net Income Before Taxes
- 168.49
- Net Income
- 123.93
- Diluted Normalized EPS
- 45.32
- Period
- 2020
- Total Assets
- 669.1
- Total Liabilities
- 281.54
- Total Equity
- 387.57
- Tangible Book Valueper Share Common Eq
- 158.33
- Period
- 2020
- Cashfrom Operating Activities
- 161.26
- Cashfrom Investing Activities
- -183.62
- Cashfrom Financing Activities
- 27.16
- Net Changein Cash
- 4.8
- Period
- 2019
- Total Revenue
- 692.3
- Selling/ General/ Admin Expenses Total
- 32.48
- Depreciation/ Amortization
- 13.64
- Other Operating Expenses Total
- -1.8
- Total Operating Expense
- 523.14
- Operating Income
- 169.17
- Net Income Before Taxes
- 171.21
- Net Income
- 133.24
- Diluted Normalized EPS
- 43.66
- Period
- 2019
- Total Assets
- 481.09
- Total Liabilities
- 191.32
- Total Equity
- 289.77
- Tangible Book Valueper Share Common Eq
- 241.43
- Period
- 2019
- Cashfrom Operating Activities
- 84.09
- Cashfrom Investing Activities
- -94.01
- Cashfrom Financing Activities
- 1.01
- Net Changein Cash
- -8.92
- Period
- 2025-03-31
- Total Revenue
- 203.81
- Selling/ General/ Admin Expenses Total
- 10.76
- Depreciation/ Amortization
- 9.2
- Other Operating Expenses Total
- 40.34
- Total Operating Expense
- 192.73
- Operating Income
- 11.08
- Net Income Before Taxes
- 7.34
- Net Income
- 4.2
- Diluted Normalized EPS
- 1.52
- Period
- 2025-03-31
- Total Assets
- 1182.93
- Total Liabilities
- 457.67
- Total Equity
- 725.26
- Tangible Book Valueper Share Common Eq
- 254.42
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 56.43
- Cashfrom Investing Activities
- -20.96
- Cashfrom Financing Activities
- -31.81
- Net Changein Cash
- 3.66
- Period
- 2024-12-31
- Total Revenue
- 186.86
- Selling/ General/ Admin Expenses Total
- 12.11
- Depreciation/ Amortization
- 8.99
- Other Operating Expenses Total
- 40
- Total Operating Expense
- 180.52
- Operating Income
- 6.34
- Net Income Before Taxes
- 6.36
- Net Income
- 5.46
- Diluted Normalized EPS
- 2
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 160.18
- Selling/ General/ Admin Expenses Total
- 11.35
- Depreciation/ Amortization
- 8.79
- Other Operating Expenses Total
- 42.89
- Total Operating Expense
- 166.61
- Operating Income
- -6.43
- Net Income Before Taxes
- -13.77
- Net Income
- -12.78
- Diluted Normalized EPS
- -4.52
- Period
- 2024-09-30
- Total Assets
- 1173.44
- Total Liabilities
- 457.16
- Total Equity
- 716.28
- Tangible Book Valueper Share Common Eq
- 255.07
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 82.06
- Cashfrom Investing Activities
- -9.26
- Cashfrom Financing Activities
- -67.62
- Net Changein Cash
- 5.19
- Period
- 2024-06-30
- Total Revenue
- 167.92
- Selling/ General/ Admin Expenses Total
- 10.77
- Depreciation/ Amortization
- 8.78
- Other Operating Expenses Total
- 39.73
- Total Operating Expense
- 160.99
- Operating Income
- 6.93
- Net Income Before Taxes
- 2.23
- Net Income
- -0.62
- Diluted Normalized EPS
- -0.23
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 176.76
- Selling/ General/ Admin Expenses Total
- 12.37
- Depreciation/ Amortization
- 8.77
- Other Operating Expenses Total
- 37.06
- Total Operating Expense
- 199.56
- Operating Income
- -22.81
- Net Income Before Taxes
- -25.13
- Net Income
- -17.22
- Diluted Normalized EPS
- -4.08
- Period
- 2024-03-31
- Total Assets
- 1247.96
- Total Liabilities
- 518.67
- Total Equity
- 729.29
- Tangible Book Valueper Share Common Eq
- 259.92
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 83.84
- Cashfrom Investing Activities
- -64.99
- Cashfrom Financing Activities
- -4.06
- Net Changein Cash
- -4.27
- Period
- 2023-12-31
- Total Revenue
- 141.36
- Selling/ General/ Admin Expenses Total
- 12.34
- Depreciation/ Amortization
- 8.6
- Other Operating Expenses Total
- 33.9
- Total Operating Expense
- 146.18
- Operating Income
- -4.82
- Net Income Before Taxes
- -9.81
- Net Income
- -7.89
- Diluted Normalized EPS
- -2.9
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Valiant Organics Technical
Moving Average
SMA
- 5 Day433.17
- 10 Day412.16
- 20 Day366.35
- 50 Day336.18
- 100 Day310.17
- 300 Day346.02
Valiant Organics Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Heubach Colorants India
- 585.1
- -0.15
- -0.03
- 733.25
- 355.15
- 1346.61
- Astec Lifesciences
- 715
- 24.15
- 3.5
- 1487.65
- 635.95
- 1405.14
- Valiant Organics
- 462.4
- 4.35
- 0.95
- 468
- 225
- 1294.93
- Amines & Plasticizers
- 227
- 1.1
- 0.49
- 359
- 178.6
- 1266.18
- Heranba Industriesord
- 300
- 1.2
- 0.4
- 561
- 205.2
- 1200.41
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Heubach Colorants India
- 32.92
- 2.86
- 13.92
- 8.77
- Astec Lifesciences
- -
- 5.62
- -0.07
- -0.04
- Valiant Organics
- -
- 1.76
- 9.85
- 7.95
- Amines & Plasticizers
- 30.37
- 4.81
- 18.01
- 5.5
- Heranba Industriesord
- 381.69
- 1.4
- 13.97
- 7.28
Valiant Organics Shareholding
Shareholding Pattern
*Promoter pledging: 0%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 22-May-25
- Audited Results
- 13-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 24-May-24
- Audited Results
- 13-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 09-Aug-23
- Quarterly Results
- 19-May-23
- Audited Results
- 31-Jan-23
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 03-Jan-25
- 02-Dec-24
- POM
- 21-Aug-24
- 31-Jul-24
- AGM
- 16-Apr-24
- 14-Mar-24
- POM
- 15-Sept-23
- 19-May-23
- AGM
- 13-Jul-23
- 09-Jun-23
- POM
- 28-Sept-22
- 04-Aug-22
- AGM
- 17-Jun-22
- 13-May-22
- POM
- 29-Sept-21
- 14-Aug-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 31-Jan-23
- 10-Feb-23
- 10-Feb-23
- 1
- 25-May-22
- 21-Sept-22
- 20-Sept-22
- 3.5


